Company / Accounts Receivable
Pulmonx Corp Accounts Receivable History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$12.1M
FY2025
5-year range
$6.6M / $13.1M
FY2021-FY2025
Trend
-8.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$12M in FY2025 with a 5-year CAGR of +23.3%.
Remained stable around $12M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +11.6%
- 5-Year CAGR
- +23.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +23.3%, indicating consistent growth.
- In FY2025, accounts receivable decreased 8.0% year-over-year.
- Peak accounts receivable was recorded in FY2024.
- Lowest accounts receivable in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.1M | -8.0% |
| FY2024 | $13.1M | +8.4% |
| FY2023 | $12.1M | +39.5% |
| FY2022 | $8.7M | +32.2% |
| FY2021 | $6.6M | +55.2% |
| FY2020 | $4.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026